InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was conducted in 2008 to 2009.

That came as the total number of settlements reached 120 in 2011,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Taiwan: Dual-track patent validity determination (sponsored) http://t.co/Q1mQHUpPDC

Mar 3 2015 04:00 ·  reply ·  retweet ·  favourite
ManagingIP profile

Vietnam: Patent infringement judgment sets precedent (sponsored) http://t.co/2kF1EsrMKt

Mar 3 2015 03:00 ·  reply ·  retweet ·  favourite
ManagingIP profile

Australia: Flexibility in extension of patent term provisions (sponsored) http://t.co/eGrrBjSI5G

Mar 3 2015 01:45 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

March 2015

Inside Beijing’s new IP Court

Peter Leung visited Beijing’s new IP Court and interviewed Judge Chen Jinchuan, vice president of the Court, about its aims, its first cases and why he listens to French radio every morning. Plus: more news and analysis on China’s new IP Courts



Most read articles

Supplements